Four of the Top ETFs to Buy and Hold Heading into 2025

One of the best ways to make money in any market is with outperforming ETFs.

Look at the US Select Quality Equity Fund (GQEPX), for example.

The fund, which invests in high-quality companies with attractively priced future growth prospects in the U.S., “returned 137% to investors over the past five years, while the broad market index has seen a total return of 109% in that time,” as reported by CNBC.

Helping, some of its top holdings include Eli Lilly, Meta Platforms, Philip Morris, Microsoft, Coca-Cola, AT&T and. Walmart to name a few. Better, after outperforming the S&P 500 over the last five years, we expect for it to do the same over the next five.

Aside from GQEPX, here are three other ETFs you may want to buy heading into 2025.

Global X Super Dividend U.S. ETF

With a yield of 6%, the Global X Super Dividend U.S. ETF (DIV) invests in some of the highest dividend-yielding stocks in the U.S. Some of those top holdings include Spire, Kinder Morgan, Omega Healthcare, Philip Morris, Duke Energy, AT&T and Dominion Energy to name just a few.
The DIV ETF has an expense ratio of 0.45%.

Fidelity High Dividend ETF

With a yield of 2.87% and an expense ratio of 0.15%, the Fidelity High Dividend ETF (FDVV) tracks the Fidelity High Dividend Index, which is designed to reflect the performance of stocks of large- and mid-capitalization dividend-paying companies that are expected to continue to pay and grow their dividends.

JPMorgan Nasdaq Equity Premium Equity Income ETF

With a yield of 9.72%, the JPMorgan Nasdaq Equity Premium Equity Income ETF (JEPQ) generates income by selling options and by investing in U.S. large-cap growth stocks. All of which allows it to deliver a monthly income stream through options premiums and stock dividends. Even better, investors have also benefited from the ETF’s appreciation. JEPQ has an expense ratio of 0.35% at the moment.

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.